Patent · US Active

CD4+ T survivin epitopes and uses thereof

US9687539B2 · kind B2 · utility

3Cited by

1References

15Claims

0Family size

Assignee

COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR

Inventors

Xiaofei Wang · Shanghai, CN
Gaetan Munier · Orsay, FR
Sandra Moratille · Sainte-Geneviève-des-Bois, FR
Helene Nuyttens · Paris, FR
Bernard Maillere · Versailles, FR

Key dates

Filing date	Oct 9, 2014
Grant date	Jun 27, 2017
Priority date	—
Expiry date	Oct 9, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention concerns CD4+ T survivin epitopes and their vaccines and diagnostic uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.